Literature DB >> 2992336

Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States. Centers for Disease Control, Department of Health and Human Services.

.   

Abstract

Since the first case definition of the acquired immunodeficiency syndrome was published in 1982, minor revisions have been made in the list of diseases used as indicators of underlying cellular immunodeficiency, and, more recently, the human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) has been identified as the cause of the syndrome. To reflect these changes, the Conference of State and Territorial Epidemiologists suggested resolutions to the case definition of the syndrome that the Centers for Disease Control will immediately adopt. These revisions will result in the reclassification of less than 1% of cases previously reported.

Entities:  

Mesh:

Year:  1985        PMID: 2992336

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  8 in total

1.  Non-Hodgkin's lymphoma among patients infected with human immunodeficiency virus: the experience of a single center in Brazil.

Authors:  Paula Yurie Tanaka; Luis Fernando Pracchia; Edenilson Eduardo Calore
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

Review 2.  Abnormalities of hematopoiesis in the acquired immunodeficiency syndrome.

Authors:  A Ganser
Journal:  Blut       Date:  1988-02

3.  The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.

Authors:  Sharon Pipkin; Susan Scheer; Ijeoma Okeigwe; Sandra Schwarcz; David H Harris; Nancy A Hessol
Journal:  AIDS       Date:  2011-02-20       Impact factor: 4.177

4.  Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.

Authors:  Amanda Mocroft; Jonathan A C Sterne; Matthias Egger; Margaret May; Sophie Grabar; Hansjakob Furrer; Caroline Sabin; Gerd Fatkenheuer; Amy Justice; Peter Reiss; Antonella d'Arminio Monforte; John Gill; Robert Hogg; Fabrice Bonnet; Mari Kitahata; Schlomo Staszewski; Jordi Casabona; Ross Harris; Michael Saag
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

Review 5.  Molecular pathology of AIDS-related lymphomas. Biologic aspects and clinicopathologic heterogeneity.

Authors:  G Gaidano; C Pastore; C Lanza; U Mazza; G Saglio
Journal:  Ann Hematol       Date:  1994-12       Impact factor: 3.673

6.  Inflammatory demyelinating polyradiculoneuropathy associated with human immunodeficiency virus infection.

Authors:  S Przedborski; C Liesnard; P Voordecker; J M Gerard; H Taelman; S Sprecher; M Goldman; J Hildebrand
Journal:  J Neurol       Date:  1988-07       Impact factor: 4.849

7.  Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases.

Authors:  H Budka; G Costanzi; S Cristina; A Lechi; C Parravicini; R Trabattoni; L Vago
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

8.  Treatment of AIDS related non-Hodgkin's lymphoma with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: results of a phase II study.

Authors:  Anil Tulpule; Byron M Espina; A B Pedro Santabarbara; Maria Palmer; Joanne Schiflett; William Boswell; Susan Smith; Alexandra M Levine
Journal:  Invest New Drugs       Date:  2004-01       Impact factor: 3.850

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.